Other OTC - Delayed Quote USD

BioSyent Inc. (BIOYF)

6.28 0.00 (0.00%)
At close: April 22 at 2:25 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
31,590.30
31,590.30
27,925.19
28,618.22
22,332.17
Cost of Revenue
5,992.36
5,992.36
5,067.30
5,980.36
4,908.32
Gross Profit
25,597.94
25,597.94
22,857.88
22,637.86
17,423.85
Operating Expense
18,063.69
18,063.69
15,951.04
14,390.23
12,298.23
Operating Income
7,534.25
7,534.25
6,906.84
8,247.63
5,125.61
Net Non Operating Interest Income Expense
1,062.71
1,062.71
448.65
51.80
170.20
Other Income Expense
-63.11
-63.11
75.16
78.99
-58.83
Pretax Income
8,533.85
8,533.85
7,430.65
8,378.42
5,236.98
Tax Provision
2,073.73
2,073.73
1,972.31
2,096.86
1,441.64
Net Income Common Stockholders
6,460.13
6,460.13
5,458.35
6,281.57
3,795.34
Diluted NI Available to Com Stockholders
6,460.13
6,460.13
5,458.35
6,281.57
3,795.34
Basic EPS
0.54
--
0.44
0.49
0.29
Diluted EPS
0.53
--
0.43
0.49
0.29
Basic Average Shares
11,949.90
--
12,303.12
12,689.16
12,977.46
Diluted Average Shares
12,170.41
--
12,540.64
12,871.28
13,094.30
Total Operating Income as Reported
7,471.14
7,471.14
6,982.00
8,183.20
5,030.02
Total Expenses
24,056.05
24,056.05
21,018.35
20,370.59
17,206.56
Net Income from Continuing & Discontinued Operation
6,460.13
6,460.13
5,458.35
6,281.57
3,795.34
Normalized Income
6,507.90
6,507.90
5,403.14
6,316.06
3,837.97
Interest Income
1,131.12
1,131.12
525.80
137.05
263.14
Interest Expense
68.41
68.41
77.14
85.25
92.94
Net Interest Income
1,062.71
1,062.71
448.65
51.80
170.20
EBIT
8,602.26
8,602.26
7,507.79
8,463.67
5,329.92
EBITDA
9,057.60
9,057.60
7,958.79
8,920.77
5,840.34
Reconciled Cost of Revenue
5,992.36
5,992.36
5,067.30
5,980.36
4,908.32
Reconciled Depreciation
455.34
455.34
451.00
457.11
510.42
Net Income from Continuing Operation Net Minority Interest
6,460.13
6,460.13
5,458.35
6,281.57
3,795.34
Total Unusual Items Excluding Goodwill
-63.11
-63.11
75.16
-46.01
-58.83
Total Unusual Items
-63.11
-63.11
75.16
-46.01
-58.83
Normalized EBITDA
9,120.72
9,120.72
7,883.63
8,966.78
5,899.17
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-15.34
-15.34
19.95
-11.51
-16.19
12/31/2020 - 2/22/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade